Clinical Trials in Ohio

Showing 20421-20440 of 20,938 trials

Depo-Provera: Bone Mineral Density and Total Body Calcium in Adolescent DP150CI Users and Non-Hormonal Contraception

NCT00139685

To evaluate and compare Bone Mineral Density (BMD) in adolescent Depo-Provera Contraceptive Injection (DP150CI) users during depo medroxyprogesterone acetate (DMPA) therapy and following discontinuation of DMPA. Another group electing non-hormonal contraception or abstinence will be recruited as a reference population, across all study sites. The primary variable is BMD, measured by Dual Energy X-ray Absorptiometry (DXA). Secondary variables are: Total Body Composition\& Total Body Calcium (TBC), measured by Dual Energy X-ray Absorptiometry (DXA), and surrogate biologic BMD markers. Safety will be evaluated by adverse event reporting, laboratory evaluations, pregnancies, weight and vital signs.

ContraceptionBone Density

Pfizer350 participantsStarted Apr 1998

Los Angeles, California, United States • Palo Alto, California, United States • Torrance, California, United States +9 more locations

COMPLETED32 miles

Perceived Changes in Body Build and Image in Patients Who Are Now Taking or Recently Have Stopped Taking Anti-HIV Drugs

NCT00006290

The purpose of this study is to learn how changes in body build affect the lives of people taking anti-HIV medications. By learning this, a set of questions can be created to help understand how changes in body build and image affect people living with HIV infection. A set of questions used to measure body image might be useful in future HIV studies. It may help doctors understand patient concerns about their body image and why some patients stop taking their anti-HIV medications.

HIV InfectionsLipodystrophy

National Institute of Allergy and Infectious Diseases (NIAID)60 participants

San Diego, California, United States • Baltimore, Maryland, United States • Columbus, Ohio, United States +1 more locations

Depo-Provera: Bone Mineral Density and Total Body Calcium in Adolescent DP150CI Users and Non-Hormonal Contraception

Perceived Changes in Body Build and Image in Patients Who Are Now Taking or Recently Have Stopped Taking Anti-HIV Drugs

Find Trials by Condition in Ohio

Phase II CT-2103/Carboplatin in Ovarian Cancer

A Study of Women With an Early Diagnosis of Breast Cancer, Taking Celecoxib Between the Biopsy and Lumpectomy/Mastectomy

Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients

Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia

A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)

Study of KOS-862 (Epothilone D) in Metastatic Prostate Cancer

SLV308 for Treatment of Patients With Early Parkinson's Disease

The Effect of Infant Feeding on Stool Characteristics

Effectiveness of the Early Addition of Abacavir to an Anti-HIV Drug Combination

Chemoprevention of Oral Premalignant Lesions

Assessment of Whole Gut Transit Time Using the SmartPill Capsule

Optimizing Prograf® Therapy in Renal Transplant Patients

Study of Five Different Methods Of Delivering A Lifestyle Modification Program for Weight Loss

Safety, Tolerability and Immunogenicity of Recombinant Anthrax Vaccine Compared With Anthrax Vaccine Adsorbed

Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) Failure

Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis

Efficacy of XP20B Following Bunionectomy Surgery

Long-Term Follow-Up Study of Psoriasis Patients